arrow
Return

CSBB-ConeExclusion, Adapting Structure Based Solution Virtual Screening to Libraries on Solid Support

delete2013-11-22
delete1
PRE
AI
S
Steven Shave *
M
Manfred Auer
DOI:10.1021/ci400371qdelete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Combinatorial chemical libraries produced on solid support offer fast and cost-effective access to a large number of unique compounds. If such libraries are screened directly on-bead, the speed at which chemical space can be explored by chemists is much greater than that addressable using solution based synthesis and screening methods. Solution based screening has a large supporting body of software such as structure-based virtual screening tools which enable the prediction of protein ligand complexes. Use of these techniques to predict the protein bound complexes of compounds synthesized on solid support neglects to take into account the conjugation site on the small molecule ligand. This may invalidate predicted binding modes, the linker may be clashing with protein atoms. We present CSBB-ConeExclusion, a methodology and computer program which provides a measure of the applicability of solution dockings to solid support. Output is given in the form of statistics for each docking pose, a unique 2D visualization method which can be used to determine applicability at a glance, and automatically generated PyMol scripts allowing visualization of protein atom incursion into a defined exclusion volume. CSBB-ConeExdusion is then exemplarically used to determine the optimum attachment point for a purine library targeting cyclin-dependent kinase 2 CDK2.
Keywords:
ROSCOVITINE
VALIDATION
DATABASES
DOCKING
INHIBITOR
TARGETS
KINASES
POTENT

Journal

Journal of Chemical Information and Modeling cover
Journal of Chemical Information and Modeling
IF:
5.3
Papers:
9.2K
Citations:
4.0W

Organization

U
University of Edinburgh
Scholars:
5.2W
Papers: 4.6W
Citations: 71
Cited Papers

Cited Papers

Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomas
err2016-01-01
err0
PREAI
errTuukka Veija; Virinder Kaur Sarhadi; Virve Koljonen; Tom Bohling; Sakari Knuutila
errShare
errSave
CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases
err2008-06-23
err166
PREAI
errBettayeb, K.; Oumata, N.; Echalier, A.; Ferandin, Y.; Endicott, J. A.; Galons, H.; Meijer, L.
errShare
errSave
errShare
errSave
Redilation of e‐PTFE covered CP stents
err2008-07-24
err0
PREAI
errGianfranco Butera; Gianpiero Gaio; Mario Carminati
errShare
errSave
Privileged scaffolds for library design and drug discovery
err2010-06-01
err1.4K
errOAAI
errWelsch, Matthew E.; Snyder, Scott A.; Stockwell, Brent R.
errShare
errSave
The SAGE Handbook of Organizational Discourse
err
IF0
err2004-01-01
err0
PREAI
errD. Grant; C. Hardy; C. Oswick; L. Putnam
errShare
errSave
researcher View more